Full Text
Utilization Patterns Of The First US Biosimilar, Filgrastim-Sndz, Observed Between 2015 And 2017 In A Medical Transcription Database

Abstract

Authors

K Smoyer B Ó Hartaigh

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×